ATE303386T1 - Das citrat-salz des 5,8,14,- triazatetracyclo(10.3.1.02,11.04,9)-hexadeca- 2(11),3,5,7,9-pentaens - Google Patents

Das citrat-salz des 5,8,14,- triazatetracyclo(10.3.1.02,11.04,9)-hexadeca- 2(11),3,5,7,9-pentaens

Info

Publication number: ATE303386T1
Authority: AT; Austria
Prior art keywords: triazatetracyclo; pentaene; hexadeca; citrate salt; citrate
Prior art date: 2001-05-14

Application number

AT02724553T

Other languages

English (en)

Inventor

Philip James Johnson

Peter Robert Rose

Lewin Theophilus Wint

Glenn Robert Williams

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-14

Filing date

2002-04-26

Publication date

2005-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23117854&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE303386(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-04-26 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2005-09-15 Application granted granted Critical

2005-09-15 Publication of ATE303386T1 publication Critical patent/ATE303386T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Addiction (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Dermatology (AREA)
Psychology (AREA)
Cardiology (AREA)
Virology (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Toxicology (AREA)
Obesity (AREA)
Hematology (AREA)
Oncology (AREA)
Anesthesiology (AREA)
Child & Adolescent Psychology (AREA)
Endocrinology (AREA)

AT02724553T 2001-05-14 2002-04-26 Das citrat-salz des 5,8,14,- triazatetracyclo(10.3.1.02,11.04,9)-hexadeca- 2(11),3,5,7,9-pentaens ATE303386T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29086301P	2001-05-14	2001-05-14
PCT/IB2002/001450 WO2002092597A1 (en)	2001-05-14	2002-04-26	The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.0?2,11.04.9¿)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof

Publications (1)

Publication Number	Publication Date
ATE303386T1 true ATE303386T1 (de)	2005-09-15

Family

ID=23117854

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02724553T ATE303386T1 (de)	2001-05-14	2002-04-26	Das citrat-salz des 5,8,14,- triazatetracyclo(10.3.1.02,11.04,9)-hexadeca- 2(11),3,5,7,9-pentaens

Country Status (37)

Country	Link
US (1)	US6787549B2 (de)
EP (1)	EP1390366B1 (de)
JP (1)	JP4137645B2 (de)
KR (1)	KR20040008175A (de)
CN (1)	CN1509288A (de)
AP (1)	AP1429A (de)
AR (1)	AR035889A1 (de)
AT (1)	ATE303386T1 (de)
BG (1)	BG108344A (de)
CA (1)	CA2446988A1 (de)
CZ (1)	CZ20032917A3 (de)
DE (1)	DE60205888T2 (de)
DO (1)	DOP2002000390A (de)
DZ (1)	DZ3503A1 (de)
EA (1)	EA005529B1 (de)
EE (1)	EE200300557A (de)
ES (1)	ES2245731T3 (de)
GT (1)	GT200200081A (de)
HR (1)	HRP20030911A2 (de)
HU (1)	HUP0304085A3 (de)
IL (1)	IL157874A0 (de)
IS (1)	IS6956A (de)
MA (1)	MA27021A1 (de)
MX (1)	MXPA03010365A (de)
MY (1)	MY134123A (de)
NO (1)	NO20035035D0 (de)
NZ (1)	NZ528209A (de)
OA (1)	OA12600A (de)
PA (1)	PA8545001A1 (de)
PE (1)	PE20021095A1 (de)
PL (1)	PL366774A1 (de)
SK (1)	SK13372003A3 (de)
TN (1)	TNSN03112A1 (de)
UA (1)	UA73421C2 (de)
UY (1)	UY27287A1 (de)
WO (1)	WO2002092597A1 (de)
ZA (1)	ZA200307234B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999035131A1 (en) *	1997-12-31	1999-07-15	Pfizer Products Inc.	Aryl fused azapolycyclic compounds
DK1448235T3 (da)	2001-11-30	2007-07-02	Pfizer Prod Inc	Orale, farmaceutiske sammensætninger af 5,8,14-triaza-tetracyclo[10.3.1.0(2,11).0(4.9)]-hexadeca-2(11),3,5,7,9-pentaen med kontrolleret frigivelse
CA2525874C (en) *	2003-05-20	2007-11-27	Pfizer Products Inc.	Pharmaceutical compositions of varenicline
US20050043407A1 (en) *	2003-08-22	2005-02-24	Pfizer Inc	Pharmaceutical composition for the prevention and treatment of addiction in a mammal
KR20090086071A (ko) *	2006-11-09	2009-08-10	화이자 프로덕츠 인코포레이티드	니코틴 중간체의 다형체
US8440825B2 (en)	2008-03-06	2013-05-14	Medichem S.A.	Fumaric acid salt of varenicline
US8039620B2 (en)	2008-05-22	2011-10-18	Teva Pharmaceutical Industries Ltd.	Varenicline tosylate, an intermediate in the preparation process of varenicline L-tartrate
US20090318460A1 (en) *	2008-05-26	2009-12-24	Glenmark	Amorphous varenicline tartrate and process for the preparation thereof
WO2009155403A2 (en) *	2008-06-19	2009-12-23	Teva Pharmaceutical Industries Ltd.	Processes for the preparation of varenicline and intermediates thereof
US20100010221A1 (en) *	2008-07-10	2010-01-14	Revital Lifshitz-Liron	Processes for purifying varenicline l-tartrate salt and preparing crystalline forms of varenicline l-tartrate salt
PT2376499E (pt) *	2008-12-11	2015-06-03	Cti Biopharma Corp	Sal citrato de 11-(2-pirrolidin-1-il-etoxi)-14,19-dioxa- 5,7,26-triaza-tetraciclo[19.3.1.1(2,6)1(8,12)]heptacosa- 1(25),2(26),3,5,8,10,1 (27),16,21,23-decaeno
US8080584B2 (en)	2009-01-23	2011-12-20	Teva Pharmaceuticals Industries, Ltd.	Delayed release rasagiline citrate formulation
US20120093887A1 (en)	2009-06-10	2012-04-19	Actavis Group Ptc Ehf	Amorphous varenicline tartrate co-precipitates
US8178537B2 (en)	2009-06-22	2012-05-15	Teva Pharmaceutical Industries Ltd.	Solid state forms of varenicline salts and processes for preparation thereof
WO2011140431A1 (en)	2010-05-06	2011-11-10	Teva Pharmaceutical Industries Ltd.	Varenicline salts and crystal forms thereof
WO2013163917A1 (zh)	2012-04-13	2013-11-07	连云港金康和信药业有限公司	化合物jk12a及其制备
WO2018154395A2 (en)	2018-06-11	2018-08-30	Alvogen Malta Operations (Row) Ltd	Controlled release pharmaceutical composition of varenicline
EP3756653A1 (de) *	2019-06-28	2020-12-30	Alfred E. Tiefenbacher (GmbH & Co. KG)	Mikropartikuläres vareniclin-citrat
WO2021188563A1 (en) *	2020-03-16	2021-09-23	Chengdu Scimount Pharmatech Co., Ltd.	5-ht3 receptor modulator, the crystalline form, methods of making, and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999035131A1 (en) *	1997-12-31	1999-07-15	Pfizer Products Inc.	Aryl fused azapolycyclic compounds
IL137937A0 (en) *	1999-08-27	2001-10-31	Pfizer Prod Inc	A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal

2002
- 2002-04-26 ES ES02724553T patent/ES2245731T3/es not_active Expired - Lifetime
- 2002-04-26 JP JP2002589481A patent/JP4137645B2/ja not_active Expired - Fee Related
- 2002-04-26 DO DO2002000390A patent/DOP2002000390A/es unknown
- 2002-04-26 OA OA1200300290A patent/OA12600A/en unknown
- 2002-04-26 CZ CZ20032917A patent/CZ20032917A3/cs unknown
- 2002-04-26 DE DE60205888T patent/DE60205888T2/de not_active Expired - Fee Related
- 2002-04-26 SK SK1337-2003A patent/SK13372003A3/sk unknown
- 2002-04-26 CA CA002446988A patent/CA2446988A1/en not_active Abandoned
- 2002-04-26 WO PCT/IB2002/001450 patent/WO2002092597A1/en active IP Right Grant
- 2002-04-26 KR KR10-2003-7014752A patent/KR20040008175A/ko not_active Application Discontinuation
- 2002-04-26 IL IL15787402A patent/IL157874A0/xx unknown
- 2002-04-26 DZ DZ023503A patent/DZ3503A1/fr active
- 2002-04-26 MX MXPA03010365A patent/MXPA03010365A/es active IP Right Grant
- 2002-04-26 AT AT02724553T patent/ATE303386T1/de not_active IP Right Cessation
- 2002-04-26 EE EEP200300557A patent/EE200300557A/xx unknown
- 2002-04-26 UA UA20031110265A patent/UA73421C2/uk unknown
- 2002-04-26 HU HU0304085A patent/HUP0304085A3/hu unknown
- 2002-04-26 CN CNA028099117A patent/CN1509288A/zh active Pending
- 2002-04-26 PL PL02366774A patent/PL366774A1/xx not_active Application Discontinuation
- 2002-04-26 EA EA200301120A patent/EA005529B1/ru not_active IP Right Cessation
- 2002-04-26 NZ NZ528209A patent/NZ528209A/en unknown
- 2002-04-26 EP EP02724553A patent/EP1390366B1/de not_active Expired - Lifetime
- 2002-05-06 US US10/139,449 patent/US6787549B2/en not_active Expired - Fee Related
- 2002-05-09 AP APAP/P/2002/002522A patent/AP1429A/en active
- 2002-05-09 GT GT200200081A patent/GT200200081A/es unknown
- 2002-05-10 PE PE2002000392A patent/PE20021095A1/es not_active Application Discontinuation
- 2002-05-13 UY UY27287A patent/UY27287A1/es not_active Application Discontinuation
- 2002-05-13 AR ARP020101735A patent/AR035889A1/es unknown
- 2002-05-13 MY MYPI20021725A patent/MY134123A/en unknown
- 2002-05-14 PA PA20028545001A patent/PA8545001A1/es unknown
2003
- 2003-07-08 TN TNPCT/IB2002/001450A patent/TNSN03112A1/fr unknown
- 2003-09-15 IS IS6956A patent/IS6956A/is unknown
- 2003-09-16 ZA ZA200307234A patent/ZA200307234B/en unknown
- 2003-11-10 HR HR20030911A patent/HRP20030911A2/xx not_active Application Discontinuation
- 2003-11-10 MA MA27390A patent/MA27021A1/fr unknown
- 2003-11-11 BG BG108344A patent/BG108344A/bg unknown
- 2003-11-13 NO NO20035035A patent/NO20035035D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EE200300557A (et)	2004-04-15
IL157874A0 (en)	2004-03-28
AP1429A (en)	2005-06-13
ES2245731T3 (es)	2006-01-16
EP1390366B1 (de)	2005-08-31
PE20021095A1 (es)	2002-12-14
KR20040008175A (ko)	2004-01-28
DE60205888T2 (de)	2006-07-06
NO20035035L (no)	2003-11-13
CZ20032917A3 (cs)	2004-07-14
HUP0304085A2 (en)	2004-04-28
US6787549B2 (en)	2004-09-07
BG108344A (bg)	2004-12-30
ZA200307234B (en)	2004-09-16
PL366774A1 (en)	2005-02-07
SK13372003A3 (sk)	2004-08-03
WO2002092597A1 (en)	2002-11-21
HRP20030911A2 (en)	2004-02-29
DZ3503A1 (de)	2002-11-21
MY134123A (en)	2007-11-30
NZ528209A (en)	2004-09-24
NO20035035D0 (no)	2003-11-13
EP1390366A1 (de)	2004-02-25
MXPA03010365A (es)	2004-03-16
AR035889A1 (es)	2004-07-21
OA12600A (en)	2006-06-09
GT200200081A (es)	2003-04-22
DE60205888D1 (de)	2005-10-06
JP4137645B2 (ja)	2008-08-20
DOP2002000390A (es)	2003-03-15
UY27287A1 (es)	2003-02-28
HUP0304085A3 (en)	2005-09-28
EA005529B1 (ru)	2005-04-28
JP2004529186A (ja)	2004-09-24
EA200301120A1 (ru)	2004-02-26
US20030149091A1 (en)	2003-08-07
CA2446988A1 (en)	2002-11-21
IS6956A (is)	2003-09-15
UA73421C2 (en)	2005-07-15
CN1509288A (zh)	2004-06-30
TNSN03112A1 (fr)	2005-12-23
MA27021A1 (fr)	2004-12-20
PA8545001A1 (es)	2003-09-05
AP2002002522A0 (en)	2002-06-30

Publication	Publication Date	Title
DE60205742D1 (de)	2005-09-29	Tartrate des 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaens
DE60205888D1 (de)	2005-10-06	Das citrat-salz des 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaens
AP2004003002A0 (en)	2004-03-31	azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
BR0216099B1 (pt)	2013-12-03	"conjunto de desgaste".
DE60214428D1 (de)	2006-10-12	1, 4-dihydro-1, 4-diphenylpyridin-derivate
EG23429A (en)	2005-07-24	Novel a-oxygenated or a-thiolated carboxylic acid phenethylamide derivatives.
RU2000118409A (ru)	2002-06-27	Антимутагенное средство
IS7131A (is)	2004-01-29	Nýjar 2,4-díamínóþíasól afleiður
IT1318986B1 (it)	2003-09-19	Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4-tetraidroisochinolin-3-carbossiammide.
ATE470655T1 (de)	2010-06-15	Substituierte 1,5-diaminopentan-3-ol-verbindungen
ITMO20020019V0 (it)	2002-05-16	,,utensile da cucina per l'essicazione di alimenti,,.
ITMI20011344A0 (it)	2001-06-27	Procedimento per la preparazione di 1,3-diossolan-2-oni
RU2000115217A (ru)	2002-06-27	Средство для лечения хронического эндометрита
UA5878S (uk)	2002-04-15	Жниварка валкова причіпна жвп - 4,9
ES1048424Y (es)	2001-12-16	Colgador perfeccionado.
ES1050049Y (es)	2002-06-16	Prenda de vestir perfeccionada.
ITMI20001600A1 (it)	2002-01-15	Procedimento per la preparazione di 5-amino-4-alo-3-alchil isossazoli.
ITTO20000397A0 (it)	2000-04-27	Procedimento perfezionato per la preparazione di 4-alchil-3-alcossianiline.
ITMC20020043A0 (it)	2002-05-23	"macchina per la bricchettatura".
ZA200308844B (en)	2004-06-28	Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease.
ITBO20000414A0 (it)	2000-07-11	Valvola cardiaca .
ES1050071Y (es)	2002-06-16	Zapatilla perfeccionada.
ES1049517Y (es)	2002-11-01	Alfombra sanitaria.
ITNA20000013V0 (it)	2000-04-04	Apparecchiatura di diagnosi corporea.
ES1048644Y (es)	2002-06-01	Colgador de sobremesa perfeccionado.

Legal Events

Date	Code	Title	Description
2006-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties